148 related articles for article (PubMed ID: 19203530)
21. Cancer research. As questions grow, Duke halts trials, launches investigation.
Couzin-Frankel J
Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
[No Abstract] [Full Text] [Related]
22. Clinical trials in cancer - SMi's Seventh Annual Conference.
Fakorede A
IDrugs; 2008 Sep; 11(9):627-9. PubMed ID: 18763208
[No Abstract] [Full Text] [Related]
23. American Society of Clinical Oncology--44th Annual Meeting. Target identification and data from preclinical and clinical studies.
Kibble A
IDrugs; 2008 Aug; 11(8):541-4. PubMed ID: 18683082
[No Abstract] [Full Text] [Related]
24. Opportunities and challenges in the development of kinase inhibitor therapy for cancer.
Sawyers CL
Genes Dev; 2003 Dec; 17(24):2998-3010. PubMed ID: 14701871
[No Abstract] [Full Text] [Related]
25. New directions in cancer research 2003: technological advances in biology, drug resistance, and molecular pharmacology.
Franks ME; Macpherson GR; Lepper ER; Figg WD; Sparreboom A
Drug Resist Updat; 2003 Dec; 6(6):301-12. PubMed ID: 14744494
[TBL] [Abstract][Full Text] [Related]
26. Translational study in cancer research.
Saijo N
Intern Med; 2002 Oct; 41(10):770-3. PubMed ID: 12412993
[TBL] [Abstract][Full Text] [Related]
27. Enrichment designs: efficiency in development of cancer treatments.
Temple RJ
J Clin Oncol; 2005 Aug; 23(22):4838-9. PubMed ID: 15983397
[No Abstract] [Full Text] [Related]
28. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 1.
Searle B
IDrugs; 2008 Aug; 11(8):545-6. PubMed ID: 18683083
[No Abstract] [Full Text] [Related]
29. American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 4.
Walker K; Kibble A; Shumoogam J
IDrugs; 2007 Aug; 10(8):523-6. PubMed ID: 17665323
[No Abstract] [Full Text] [Related]
30. Facilitating patient-centered cancer research and a new era of drug discovery.
Niederhuber JE
Oncologist; 2009 Apr; 14(4):311-2. PubMed ID: 19365096
[No Abstract] [Full Text] [Related]
31. Optimizing oncology therapeutics through quantitative translational and clinical pharmacology: challenges and opportunities.
Venkatakrishnan K; Friberg LE; Ouellet D; Mettetal JT; Stein A; Trocóniz IF; Bruno R; Mehrotra N; Gobburu J; Mould DR
Clin Pharmacol Ther; 2015 Jan; 97(1):37-54. PubMed ID: 25670382
[TBL] [Abstract][Full Text] [Related]
32. American Society of Clinical Oncology--44th Annual Meeting. Reports of clinical trial results--part 2.
Ogbighele E
IDrugs; 2008 Aug; 11(8):547-9. PubMed ID: 18683084
[No Abstract] [Full Text] [Related]
33. American society of clinical oncology - 45th annual meeting. Part 2.
Lakeram M; Kibble A
IDrugs; 2009 Jul; 12(7):404-8. PubMed ID: 19579155
[No Abstract] [Full Text] [Related]
34. American society of clinical oncology - 45th annual meeting. Part 1.
Gale S
IDrugs; 2009 Jul; 12(7):401-3. PubMed ID: 19579154
[No Abstract] [Full Text] [Related]
35. Twenty-fifth annual general meeting of the British Association for Cancer Research. Abstracts of invited and profferred papers.
Br J Cancer; 1984 Aug; 50(2):239-78. PubMed ID: 6380555
[No Abstract] [Full Text] [Related]
36. Are targeted therapies really targeted?
Schilsky RL
Clin Adv Hematol Oncol; 2003 Dec; 1(12):722-3. PubMed ID: 16258475
[No Abstract] [Full Text] [Related]
37. Advances and challenges in the use of biomarkers in clinical trials.
Chabner B
Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
[No Abstract] [Full Text] [Related]
38. The war on cancer: have we won the battle but lost the war?
Brennan R; Federico S; Dyer MA
Oncotarget; 2010 Jun; 1(2):77-83. PubMed ID: 20877440
[No Abstract] [Full Text] [Related]
39. Focus: advances in clinical cancer research.
Landis-Piwowar KR
Clin Lab Sci; 2012; 25(1):35-7. PubMed ID: 22458047
[No Abstract] [Full Text] [Related]
40. AACR-NCI-EORTC International Conference 2009.
Awada A; Lacombe D
Expert Rev Anticancer Ther; 2010 Mar; 10(3):319-20. PubMed ID: 20214512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
